Stock ZEN ZENTEK LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zentek Ltd.

Equities

ZEN

CA98942X1024

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 03:59:59 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.48 CAD +2.07% Intraday chart for Zentek Ltd. +4.23% +2.07%
Apr. 25 Zentek Ltd. Provides ZenGUARD Business Update CI
Apr. 03 Zentek Ltd. Enters into Definitive Distribution Agreement with Medwell Solutions LLC CI

Business Summary

Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company’s developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.

Number of employees: 29

Sales per Business

CAD in Million2021Weight2022Weight Delta
Nano-graphite and Graphene Materials
100.0 %
0 nan % 0 100.0 % -

Sales per region

CAD in Million2021Weight2022Weight Delta
Canada
100.0 %
0 nan % 0 100.0 % -

Managers

Managers TitleAgeSince
Gregory Fenton CEO
 Chief Executive Officer - 18-07-10
Wendy Ford DFI
 Director of Finance/CFO - 22-05-15
Adam MacIntosh CTO
 Chief Tech/Sci/R&D Officer - -
Colin van der Kuur CTO
 Chief Tech/Sci/R&D Officer - 20-02-03
Francis Dubé COO
 Chief Operating Officer - 18-05-10
Brian Bosse BRD
 Director/Board Member - 18-05-10
Nick Hansford PRN
 Corporate Officer/Principal - 20-12-31
Ryan Shacklock PRN
 Corporate Officer/Principal - -
Monique Manaigre LAW
 General Counsel - 18-04-30
James Jordan PRN
 Corporate Officer/Principal - 16-06-30

Members of the board

Members of the board TitleAgeSince
Ilse Treurnicht BRD
 Director/Board Member - 22-07-04
John Snisarenko BRD
 Director/Board Member 61 23-10-04
Francis Dubé COO
 Chief Operating Officer - 18-05-10
Eric Wallman CHM
 Chairman - 18-05-10
Brian Bosse BRD
 Director/Board Member - 18-05-10
Gregory Fenton CEO
 Chief Executive Officer - 18-07-10
Lisa Sim BRD
 Director/Board Member - 23-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 100,819,577 94,840,283 ( 94.07 %) 0 94.07 %

Shareholders

NameEquities%Valuation
Gregory Fenton
2.829 %
2,851,780 2.829 % 3 M $
Francis Dubé
0.8901 %
897,423 0.8901 % 1 M $
Brian Bosse
0.6041 %
609,086 0.6041 % 732 121 $
Scotia Capital, Inc.
0.4434 %
447,070 0.4434 % 537 378 $
Eric Wallman
0.4021 %
405,385 0.4021 % 487 273 $
Colin van der Kuur
0.2322 %
234,056 0.2322 % 281 335 $
Peter Wood
0.1660 %
167,348 0.1660 % 201 152 $
RBC Dominion Securities, Inc.
0.0821 %
82,799 0.0821 % 99 524 $
BMO Bank NA (Investment Management)
0.0661 %
66,666 0.0661 % 80 133 $
CIBC World Markets, Inc.
0.0368 %
37,100 0.0368 % 44 594 $

Company contact information

Zentek Ltd.

24 Corporate Court

N1G 5G5, Guelph

+844-730-9822

http://www.zentek.com
address Zentek Ltd.(ZEN)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ZENTEK LTD. Stock Zentek Ltd.
+2.07% 109M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ZEN Stock
  4. Company Zentek Ltd.